The Competition Board took its decision concerning the preliminary inquiry which was launched in response to the complaint claiming that the Turkish Pharmacists' Association abused its dominant position by its practices in relation to the import of pharmaceuticals which are not licensed in Turkey, or which are not offered in the market due to various reasons despite being licensed.

The Competition Board, after discussing the information, documents and observations gathered during the preliminary inquiry on its meeting of 07.07.2015, deemed the findings significant and sufficient, and took the decision numbered 15-28/335-M to initiate an investigation concerning

- the Turkish Pharmacists' Association, and
- Turkish Pharmacists' Association Commercial Enterprise

Article 6 of the Act no 4054 prohibits abuses of dominant position, and the investigation in question was launched in order to determine whether the undertaking and the association of undertakings concerned violated article 6 of the Act no 4054 by abusing their dominant positions through their exclusive practices and other conduct in the relevant product market comprised of pharmaceuticals imported from abroad.

* Investigation decisions taken by the Competition Board are announced to the public following the notification of the decision to the undertakings or associations of undertakings under investigation. These declarations, which are made within the framework of informing the public on Competition Board decisions, cannot be interpreted to mean the undertakings or associations of undertakings under investigation have violated the Act no 4054 and that they have faced or will face sanctions under the Act.